Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Shares of Diebold Nixdorf are up 2.92% at $65.63. The company is worth $2.23B, number 2700 out of 3132 on our list.
The 52-week range is $54.48 to $92.09. Today's price is about 30% of the way from the low to the high.
The stock changes hands at 21.7 times trailing earnings.
2 analysts follow the stock and the average call is "buy". The mean target, $100.00, sits 52.4% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 3 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Cheaper on P/E than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
2 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
DBD is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $100.00, 52.4% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $81.63, so shares trade 19.6% below that estimate.
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 5, 2026 10:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$65.63 is the latest print for DBD, a move of +2.92% against yesterday's close of $63.77. Today's low and high so far: $63.77 and $67.28.
Equity value comes to $2.23B at the current price. By that measure it is number 2700 of the 3132 names in our coverage.
Buyers pay 21.7 times the last twelve months of profit (EPS $2.54).
The year's floor is $54.48 and the ceiling $92.09. Shares are 28.7% away from that ceiling.
Our data shows no dividend paid by Diebold Nixdorf over the trailing twelve months.
Of 2 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $100.00, with the most cautious at $100.00 and the most optimistic at $100.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on DBD.